EP0506653A1 - Amino acid composition - Google Patents
Amino acid compositionInfo
- Publication number
- EP0506653A1 EP0506653A1 EP19870906193 EP87906193A EP0506653A1 EP 0506653 A1 EP0506653 A1 EP 0506653A1 EP 19870906193 EP19870906193 EP 19870906193 EP 87906193 A EP87906193 A EP 87906193A EP 0506653 A1 EP0506653 A1 EP 0506653A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- amino acid
- acid composition
- possibly
- ornithine
- tyrosine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 150000001413 amino acids Chemical class 0.000 title abstract 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 abstract 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 abstract 1
- 229930064664 L-arginine Natural products 0.000 abstract 1
- 235000014852 L-arginine Nutrition 0.000 abstract 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 abstract 1
- 229940024606 amino acid Drugs 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 229960003104 ornithine Drugs 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 229960004441 tyrosine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Une composition chimique, constituée essentiellement de L-arginine et de L-ornithine ainsi qu'éventuellement d'un petit mélange d'au moins un autre composant, est utilisée pour maigrir, éventuellement en conjonction avec de la L-tyrosine. Un ou plusieurs des acides aminés peuvent être remplacés par un groupe équivalent.A chemical composition, consisting essentially of L-arginine and L-ornithine as well as possibly a small mixture of at least one other component, is used to lose weight, possibly in conjunction with L-tyrosine. One or more of the amino acids can be replaced by an equivalent group.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8622417 | 1986-09-17 | ||
| GB08622417A GB2199243A (en) | 1986-09-17 | 1986-09-17 | Pharmaceutical compositions comprising ornithine and arginine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP0506653A1 true EP0506653A1 (en) | 1992-10-07 |
Family
ID=10604341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP19870906193 Withdrawn EP0506653A1 (en) | 1986-09-17 | 1987-09-17 | Amino acid composition |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0506653A1 (en) |
| AU (1) | AU7969187A (en) |
| GB (1) | GB2199243A (en) |
| WO (1) | WO1988001865A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2745498A1 (en) * | 1996-02-29 | 1997-09-05 | Giroux Jean Marc | Composition to treat obesity, improves renal tolerance and rate of weight loss |
| FR2794974B1 (en) * | 1999-06-16 | 2001-08-17 | Exsymol Sa | COSMETIC COMPOSITION FOR SLIMMING BASED ON L-ARGININE, AN ANALOG OF L-ARGININE OR A DERIVATIVE THEREOF, APPLICABLE TOPICALLY |
| US8968799B2 (en) * | 2006-09-01 | 2015-03-03 | Rise-N-Shine L.L.C. | Time delayed release mechanism for energizing composition and method of use |
| FR2987270A1 (en) * | 2012-02-29 | 2013-08-30 | Agronomique Inst Nat Rech | COMBINATION PRODUCT FOR TREATING OVERWEIGHT AND / OR IMPROVING SILHOUETTE |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR958M (en) * | 1961-01-18 | 1961-11-27 | ||
| FR926M (en) * | 1961-01-18 | 1961-11-13 | ||
| CA939265A (en) * | 1967-11-18 | 1974-01-01 | Yoshitaka Ikezuki | Injectable compositions for alleviating the pain incurred from administrations of injections |
| ZA716628B (en) * | 1970-10-15 | 1972-06-28 | Richardson Merrell Spa | Composition and method for treatment of hepatic disease and mental fatigue |
| US3867539A (en) * | 1973-04-27 | 1975-02-18 | Us Health | Method of producing anorexia as a treatment for obesity |
| US3950529A (en) * | 1975-02-03 | 1976-04-13 | Massachusetts General Hospital | Amino acid formulations for patients with liver disease and method of using same |
| DE3166142D1 (en) * | 1980-06-09 | 1984-10-25 | Leopold & Co Chem Pharm | Infusion solution for the protection of the liver and the improvement of its functioning, and process for its production |
-
1986
- 1986-09-17 GB GB08622417A patent/GB2199243A/en not_active Withdrawn
-
1987
- 1987-09-17 AU AU79691/87A patent/AU7969187A/en not_active Abandoned
- 1987-09-17 EP EP19870906193 patent/EP0506653A1/en not_active Withdrawn
- 1987-09-17 WO PCT/GB1987/000648 patent/WO1988001865A1/en not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO8801865A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU7969187A (en) | 1988-04-07 |
| WO1988001865A1 (en) | 1988-03-24 |
| GB8622417D0 (en) | 1986-10-22 |
| GB2199243A (en) | 1988-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Birnbaum et al. | Quantitative nutritional studies with water-soluble, chemically defined diets. III. Individual amino acids as sources of “non-essential” nitrogen | |
| ES8500561A1 (en) | Pharmaceutical dermal compositions with prolonged and continuous action based on essential fatty acids | |
| ATE93142T1 (en) | CHELATED AMINO ACID COMPOSITIONS FOR DELIVERY TO SPECIFIC TISSUE LOCATIONS. | |
| KR840003414A (en) | Pharmaceutical compositions containing 3-hydroxybutanoic acid or salts derived from these acids, and compounds derived from 3-hydroxybutanoic acid that can be used as pharmaceuticals | |
| SE8703938D0 (en) | PEPTIDE DERIVATIVES | |
| KR830006219A (en) | Method for preparing amino acid derivative | |
| ATE58292T1 (en) | MEDICATION CONTAINING L-DOPA. | |
| KR870002109A (en) | Process for preparing di-t-butylphenol compound | |
| BE901007A (en) | SPREAD RELEASE PHARMACEUTICAL TABLETS AND PROCESS FOR PREPARING THE SAME. | |
| Connors et al. | The pharmacology and tumour growth inhibitory activity of 1-aminocyclopentane-1-carboxylic acid and related compounds | |
| SE8901041D0 (en) | ANTITROMOBOTIC PHARMACEUTICAL PREPARATIONS AND PROCEDURES FOR THEIR PREPARATION | |
| EP0506653A1 (en) | Amino acid composition | |
| FR2355865A1 (en) | IMPROVEMENTS TO POLYESTER / POLYAMIDE CO-CONDENSATES | |
| FR2401659A1 (en) | COMPOSITION INTENDED TO IMPROVE THE REPRODUCTIVE POWER OF ANIMALS, CONTAINING AN ASSOCIATION BASED ON L-DOPA AND AN AMIN ACID | |
| WO2002102360A3 (en) | Compositions based on branched chain amino acids for improving the myocardial ventricular function in patients suffering from diabetes | |
| CA2047802A1 (en) | Pharmaceutical compositions | |
| WO2002002092A3 (en) | Compositions based on aminoacids, suitable for improving muscle performance | |
| GR871549B (en) | Amino acid derivative anticonvulsant | |
| FR2422403A1 (en) | FAST-ACTING DIURETIC THERAPEUTIC COMPOSITIONS BASED ON 4-CHLORO-N-FURFURYL-5-SULFAMOYLANTHRANILIC ACID AND PTERIDINE COMPOUNDS | |
| RU95113498A (en) | Linear or cyclic oligopeptides showing affinity to opioid receptors, pharmaceutical composition, treatment method | |
| EP0012670A1 (en) | Fertilizer composed of natural products | |
| KR920700683A (en) | solubilization of t-PA | |
| EP0063328A3 (en) | Compositions containing secretin and method for preventing the adsorption of secretin | |
| Campbell et al. | Paradoxical decrease in norepinephrine content of adult mouse spleen and heart after neonatal nerve growth factor treatment | |
| Toyoda et al. | Preparation and properties of human kappa-casein-like fraction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19890914 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
| 17Q | First examination report despatched |
Effective date: 19921029 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 19930309 |